Pharmacist-Driven Oral Oncolytic Medication Education and Consent.

Bowles, Harmony; Tawfik, Bernard; Abernathy, Janet; Lauer, Richard; Hashemi, Neda; Dayao, Zoneddy

Bowles, Harmony; Tawfik, Bernard; Abernathy, Janet; Lauer, Richard; Hashemi, Neda; Dayao, Zoneddy.

Afiliación

Bowles H; Section of Hematology and Oncology, Division of Internal Medicine, University of New Mexico Comprehensive Cancer Center, Albuquerque, NM.
Tawfik B; Section of Hematology and Oncology, Division of Internal Medicine, University of New Mexico Comprehensive Cancer Center, Albuquerque, NM.
Abernathy J; Section of Hematology and Oncology, Division of Internal Medicine, University of New Mexico Comprehensive Cancer Center, Albuquerque, NM.
Lauer R; Section of Hematology and Oncology, Division of Internal Medicine, University of New Mexico Comprehensive Cancer Center, Albuquerque, NM.
Hashemi N; Section of Hematology and Oncology, Division of Internal Medicine, University of New Mexico Comprehensive Cancer Center, Albuquerque, NM.
Dayao Z; Section of Hematology and Oncology, Division of Internal Medicine, University of New Mexico Comprehensive Cancer Center, Albuquerque, NM.

JCO Oncol Pract ; 16(10): e1209-e1215, 2020 10.

Article en En | MEDLINE | ID: mdl-32459565

Asunto(s)

Antineoplásicos; Consentimiento Informado; Educación del Paciente como Asunto; Farmacéuticos; Administración Oral; Antineoplásicos/uso terapéutico; Humanos; México

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Farmacéuticos / Educación del Paciente como Asunto / Consentimiento Informado / Antineoplásicos Límite: Humans País/Región como asunto: Mexico Idioma: En Revista: JCO Oncol Pract Año: 2020 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google